1. Kaakoush NO, Castan~o-Rodríguez N, Mitchell HM, Man SM. Global epidemiology of Campylobacter infection. Clin Microbiol Rev 2015;28:687–720. doi: 10.1128/ CMR.00006-15.
2. Blaser MJ. Epidemiologic and clinical features of Campylobacter jejuni infections. J Infect Dis 1997;176:S103–5. doi: 10.1086/513780.
3. Skirrow MB, Jones DM, Sutcliffe E, Benjamin J. Campylobacter bacteraemia in Eng- land and Wales, 1981-91. Epidemiol Infect 1993;110:567–73.
4. Vetchapitak T, Misawa N. Current status of Campylobacter food poisoning in Japan. Food Saf 2019;7:61–73. doi: 10.14252/foodsafetyfscj.d-19-00001.
5. Feodoroff B, de Haan CPA, Ellstro€m P, Sarna S, H€anninen ML, Rautelin H. Clonaldistribution and virulence of Campylobacter jejuni isolates in blood. Emerg Infect Dis 2013;19:1653–5. doi: 10.3201/eid1910.121537.
6. Wu Z, Sippy R, Sahin O, Plummer P, Vidal A, Newell D, et al. Genetic diversity and antimicrobial susceptibility of Campylobacter jejuni isolates associated with sheep abortion in the United States and Great Britain. J Clin Microbiol 2014;52:1853–61. doi: 10.1128/JCM.00355-14.
7. Asakura H, Bru€ggemann H, Sheppard SK, Ekawa T, Meyer TF, Yamamoto S, et al. Molecular evidence for the thriving of Campylobacter jejuni ST-4526 in Japan. PLoS One 2012;7:e48394. doi: 10.1371/journal.pone.0048394.
8. Yamada K, Saito R, Muto S, Sasaki M, Murakami H, Aoki K, et al. Long-term obser- vation of antimicrobial susceptibility and molecular characterisation of Campylo- bacter jejuni isolated in a Japanese general hospital 2000−2017. J Glob Antimicrob Resist 2019;18:59–63. doi: 10.1016/j.jgar.2019.02.001.
9. Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K, et al. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre´ syndrome after Cam- pylobacter jejuni enteritis. J Infect Dis 2006;193:547–55. doi: 10.1086/499969.
10. Yabe S, Higuchi W, Iwao Y, Takano T, Razvina O, Reva I, et al. Molecular typing of campylobacter jejuni and C. coli from chickens and patients with gastritis or guil- lain-barre´ syndrome based on multilocus sequence types and pulsed-field gel electrophoresis patterns. Microbiol Immunol 2010;54:362–7. doi: 10.1111/ j.1348-0421.2010.00222.x.
11. Winters DK, Slavik MF. Evaluation of a PCR based assay for specific detection of Campylobacter jejuni in chicken washes. Mol Cell Probes 1995;9:307–10. doi: 10.1016/S0890-8508(95)91556-7.
12. Linton D, Lawson AJ, Owen RJ, Stanley J. PCR detection, identification to species level, and fingerprinting of campylobacter jejuni and campylobacter coli direct from diarrheic samples. J Clin Microbiol 1997;35:2568–72. doi: 10.1128/ jcm.35.10.2568-2572.1997.
13. Dingle KE, Colles FM, Wareing DRA, Ure R, Fox AJ, Bolton FE, et al. Multilocus sequence typing system for Campylobacter jejuni. J Clin Microbiol 2001;39:14–23. doi: 10.1128/JCM.39.1.14-23.2001.
14. Poly F, Serichatalergs O, Schulman M, Ju J, Cates CN, Kanipes M, et al. Discrimina- tion of major capsular types of Campylobacter jejuni by multiplex PCR. J Clin Microbiol 2011;49:1750–7. doi: 10.1128/JCM.02348-10.
15. Poly F, Serichantalergs O, Kuroiwa J, Pootong P, Mason C, Guerry P, et al. Updated campylobacter jejuni capsule PCR multiplex typing system and its application to clinical isolates from south and southeast Asia. PLoS One 2015;10:e0144349. doi: 10.1371/journal.pone.0144349.
16. Clinical and Laboratory Standards Institute. CLSI guideline M45. Methods for Anti- microbial Dilution and Disk Susceptibility Testing Of Infrequently Isolated or Fas- tidious Bacteria. Malvern, PA: 2015, 3rd ed.
17. Clinical and Laboratory Standards Institute. Performance Standards for Antimi- crobial Susceptibility Testing. CLSI guideline M100. Malvern, PA: 2020, 30th ed.
18. Tang Y, Sahin O, Pavlovic N, Lejeune J, Carlson J, Wu Z, et al. Rising fluoroquino- lone resistance in Campylobacter isolated from feedlot cattle in the United States. Sci Rep 2017;7:494. doi: 10.1038/s41598-017-00584-z.
19. Francisco AP, Vaz C, Monteiro PT, Melo-Cristino J, Ramirez M, Carric¸ o JA. PHYLO- ViZ: Phylogenetic inference and data visualization for sequence based typing methods. BMC Bioinf 2012;13:87. doi: 10.1186/1471-2105-13-87.
20. Nascimento M, Sousa A, Ramirez M, Francisco AP, Carric¸ o JA, Vaz C. PHYLOViZ 2.0: Providing scalable data integration and visualization for multiple phylogenetic inference methods. Bioinformatics 2017;33:128–9. doi: 10.1093/bioinformatics/ btw582.
21. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R. Foundation for Statistical Computing. 2020.
22. R Studio Team. R Studio: Integrated Development for R. Boston, MA: R Studio, Inc.; 2020.
23. Sahin O, Terhorst SA, Burrough ER, Shen Z, Wu Z, Dai L, et al. Key role of capsular polysaccharide in the induction of systemic infection and abortion by hyperviru- lent Campylobacter jejuni. Infect Immun 2017;85:17. e00001. doi: 10.1128/IAI. 00001-17.
24. Pike BL, Guerry P, Poly F. Global distribution of Campylobacter jejuni penner sero- types: A systematic review. PLoS One 2013;8:e67375. doi: 10.1371/journal. pone.0067375.
25. Islam Z, Sarker SK, Jahan I, Farzana KS, Ahmed D, Faruque ASG, et al. Capsu- lar genotype and lipooligosaccharide locus class distribution in Campylobac- ter jejuni from young children with diarrhea and asymptomatic carriers in Bangladesh. Eur J Clin Microbiol Infect Dis 2018;37:723–8. doi: 10.1007/ s10096-017-3165-7.
26. Rojas JD, Reynolds ND, Pike BL, Espinoza NM, Kuroiwa J, Jani V, et al. Distribution of capsular types of Campylobacter jejuni Isolates from symptomatic and asymp- tomatic children in peru. Am J Trop Med Hyg 2019;101:541–8. doi: 10.4269/ ajtmh.18-0994.
27. Kivisto€ RI, Kovanen S, Skarp-De Haan A, Schott T, Rahkio M, Rossi M, et al. Evolu- tion and comparative genomics of Campylobacter jejuni ST-677 clonal complex. Genome Biol Evol 2014;6:2424–38. doi: 10.1093/gbe/evu194.
28. European Food Safety Authority and European Centre for Disease Prevention and Control. The European Union summary report on antimicrobial resistance in zoo- notic and indicator bacteria from humans, animals and food in 2017. EFSA J 2019;17:5598. doi: 10.2903/j.efsa.2019.5598.
29. Luo N, Sahin O, Lin J, Michel LO, Zhang Q. In vivo selection of Campylobacter iso- lates with high levels of fluoroquinolone resistance associated with gyrA muta- tions and the function of the CmeABC efflux pump. Antimicrob Agents Chemother 2003;47:390–4. doi: 10.1128/AAC.47.1.390-394.2003.
30. Bachoual R, Ouabdesselam S, Mory F, Lascols C, Soussy CJ, Tankovic J. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Microb Drug Resist 2001;7:257–61. doi: 10.1089/10766290152652800.
31. Haruna M, Sasaki Y, Murakami M, Ikeda A, Kusukawa M, Tsujiyama Y, et al. Prevalence and Antimicrobial Susceptibility of Campylobacter in BroilerFlocks in Japan. Zoonoses Public Health 2012;59:241–5. doi: 10.1111/j.1863- 2378.2011.01441.x.
32. Igimi S, Okada Y, Ishiwa A, Yamasaki M, Morisaki N, Kubo Y, et al. Antimicrobial resistance of Campylobacter: Prevalence and trends in Japan. Food Addit Contam- Part A Chem Anal Control Expo Risk Assess 2008;25:1080–3. doi: 10.1080/ 02652030802093900.
33. Tajada P, Gomez-Garces JL, Alo´s JI, Balas D, Cogollos R. Antimicrobial susceptibili- ties of Campylobacter jejuni and Campylobacter coli to 12 b-lactam agents and combinations with b-lactamase inhibitors. Antimicrob Agents Chemother1996;40:1924–5. doi: 10.1128/aac.40.8.1924.
34. Lariviere LA, Gaudreau CL TF. Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents. J Antimicrob Chemother 1986;18:681–5. doi: 10.1007/BF01962617.
35. Albert MJ, Leach A, Asche V, Hennessey J, Penner JL. Serotype distribution of Cam- pylobacter jejuni and Campylobacter coli isolated from hospitalized patients with diarrhea in central Australia. J Clin Microbiol 1992;30:207–10. doi: 10.1128/ jcm.30.1.207-210.1992.